Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetics and Genomics of Aspirin Exacerbated Respiratory Disease (AERD)

NCT04261582 is registered in ClinicalTrials.gov with National Jewish Health as lead sponsor.

NCT NCT04261582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04261582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetics and Genomics of Aspirin Exacerbated Respiratory Disease (AERD)
Lead sponsor
National Jewish Health
Phase
Observational
Overall status
Suspended
Start date
November 6, 2018
Completion date
April 30, 2022
Enrollment
245 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aspirin exacerbated respiratory disease, aspirin-sensitive asthma, nasal polyps